We use cookies for a better user experience. Read our Privacy Policy

I Agree

Bioanalytical Testing Services Market

Bioanalytical Testing Services Market (Product Type: Cell-based Assays, Virology Testing, Serology, Immunogenicity & Neutralizing Antibodies, Toxicology Services, Biomarker Testing, and Pharmacokinetic Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Bioanalytical Testing Services Market Outlook 2031

  • The global bioanalytical testing services market was valued at US$ 2.11 Bn in 2021

  • The global market is projected to advance at a CAGR of 15.7% from 2022 to 2031

  • The global bioanalytical testing services market is anticipated to reach more than US$ 8.95 Bn by 2031

Analysts’ Viewpoint on Bioanalytical Testing Services Market Scenario

Bioanalytical testing is used for quantitative determination of properties of drugs and metabolites in biological fluids, primarily blood, plasma, serum, urine, or tissue extracts. Rise in demand for biopharma products and growth in usage of biosimilars for different indications, especially diabetes and cancer, are key factors projected to drive the global bioanalytical testing services market. Most of the pharmaceutical companies, bioanalytical laboratories, and CROs are scaling up their bioanalytical services and investing in bioanalytical testing laboratories.

bioanalytical testing services market

Bioanalytical Testing Services Market Trends

Rise in demand for biopharma products and increase in need to develop novel bioanalytical assay platforms are the key factors driving investments in bioanalytical R&D and laboratories. Increase in trend of outsourcing laboratory testing services for quality check has encouraged companies to offer various types of services and solutions in the market. This is anticipated to propel the bioanalytical testing services market. Growth in merger and acquisition activities across the globe is also augmenting the demand for bioanalytical assay services. For instance, in October 2021, BioAgilytix signed an agreement to acquire Australia-based 360biolabs.

Request a sample to get extensive insights into the Bioanalytical Testing Services Market

COVID-19 Impact on Bioanalytical Testing Services Market

Bioanalytical diagnostic technologies play a crucial role in containing the COVID-19 pandemic. They are likely to help contain the future waves of the pandemic and infectious disease outbreaks. In the event of a major pandemic such as COVID-19, a combination of different diagnostic technologies (centralized and point-of-care, and reliance on multiple biomarkers) is required for effective diagnosis, treatment selection, prognosis, patient monitoring, and epidemiological surveillance. Several biotech and pharmaceutical companies have been focusing on developing effective technologies for rapid diagnosis of COVID-19. They have been concentrating on developing vaccines/therapeutics that can help mitigate the spread of the disease by ensuring appropriateness of care across all healthcare settings and achieving high-quality outcomes. This is driving the demand for bioanalytical assay services across the globe. For instance, CIRION BioPharma Research, Inc., a GLP-certified contract research laboratory based in the U.S., announced in July 2020 that it was expanding its bioanalytical testing services to support COVID-19 drug and vaccine development.

Increase in Usage of Immunogenicity and Immune-based Therapy to Propel Immunology Segment

Immunogenicity testing is required throughout the development process to assess the immune response in preclinical models using clinical samples. Immunogenicity testing examines antibodies created against a treatment. It helps establish efficacy and safety with assurance in vaccine and biologics production or gene therapy. Hence, immunology bioanalytical tests are crucial in the clinical phase for practically all modern medicines, from monoclonal antibodies (mAbs) for oncology to vaccine programs and gene & cell therapies. Any therapy that provokes an immune response requires clinical immunological testing to ensure that the response does not jeopardize patient safety. In terms of application, immunology is likely to be the fastest growing segment of the global market during the forecast period. Therefore, increase in usage of immunogenicity and immune-based therapy is projected to boost the immunology segment during the forecast period.

Request a custom report on Bioanalytical Testing Services Market

Rise in R&D Investment Augmenting Mass Spectroscopy Segment

The mass spectrometry segment is projected to account for major share of the global bioanalytical testing services market by 2031. R&D spending by pharmaceutical companies has increased significantly in the last two decades. Biopharmaceutical research is supported by investments in specialties such as biopharma and precision medicine. The study of large molecules is currently a hot topic of discussion in the bioanalytical community. Growing importance of peptides and proteins as therapeutic agents, combined with the significant opportunities provided by new MS-based technology, has opened up a whole new world for bioanalytical scientists. Rise in usage of mass spectrometers in pharmaceutical and biopharmaceutical industries and adoption of new applications in the bioanalytical testing services market are the key factors driving the mass spectroscopy segment.

Surge in Specialized Testing Services to Boost Biotech & Pharmaceuticals Companies Segment

Based on end-user, the biotech & pharmaceutical companies segment is projected to advance at a CAGR of 15.1% during the forecast period. Biotech and pharmaceutical companies are focusing on specialized testing services including gene expression analysis, liquid chromatography-mass spectrometry (LC/MS), raw material wet chemistry analysis, and metal analysis with inductive mass spectrometry (ICP-MS). Furthermore, pharmaceutical companies are increasing outsourcing of early-phase development, clinical, and laboratory testing services to boost revenue, avoid high capital spending, and decrease the time taken to validate processes and products.

Regional Outlook of Global Bioanalytical Testing Services Market

North America is projected to be a highly attractive region of the global market during the forecast period. The region accounted for more than 45% share of the global market in 2021 due to the presence of large number of patients with various chronic diseases and rise in adoption of peptides and other large molecule therapeutics. According to the Centers for Disease Control and Prevention, more than 877,500 people in the U.S. succumb to heart disease or stroke every year (i.e., one-third of all deaths). These diseases take an economic toll, costing the health care system US$ 216 Bn per year.

Europe was the second largest bioanalytical testing services market in terms of revenue in 2021. High share of the region can be ascribed to the increase in investment in biotechnology and pharmaceutical R&D activities. Furthermore, rise in in cases of chronic diseases is driving the market in Europe. For instance, cardiovascular disease (CVD) accounted for 3.9 million deaths in Europe in 2017. Around 15% of CVD deaths in the region are due to high blood sugar. Prevalence of diabetes in the region is high. It has increased rapidly in the past 10 years, rising by more than 50% in several countries in the region. Hence, increase in incidence of diseases is propelling the market in Europe.

The market in Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. Increase in clinical trial activities in emerging markets is primarily ascribed to factors such as cost savings, large treatment-naive population, retention of clinical trial participants, and constantly improving regulatory procedures. Furthermore, China's bioanalytical testing services have increased due to the growth in drug innovation and development activities in the last decade. This is expected to drive the market in the country during the forecast period.

Analysis of Key Players in Global Bioanalytical Testing Services Market

This report includes vital information about the key players operating in the global bioanalytical testing services market. Companies are focusing on strategies such as new product launches, divestiture, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. Charles River Laboratories International, Inc., Bioreliance Corporation, Intertek Group plc, Eurofins Scientific SE, BioclinResearch Laboratories, Labcorp, Wuxi AppTec, Envigo, BioAgilytix Labs, Syneos Health, and Frontage Labs are the prominent players operating in the global bioanalytical testing services market.

Key Developments in Global Bioanalytical Testing Services Market

  • In October 2021, SGS completed clinical bioanalysis laboratory expansion in France. The addition includes a new 800 m2 building that houses additional drug development equipment as well as office space. The expansion includes chromatography and immunoassay laboratories and bioanalytical testing services, which are expected to increase production capacity. The site's existing capabilities would be supplemented with new capabilities such as mass spectrometry, immunoanalysis, clinical bioanalysis, and cell-based bioassays.
  • In September 2021, Envigo announced a partnership with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse mode
  • In September 2020, Almac Sciences, a member of the Almac Group, announced the addition of biologics testing to its existing suite of analytical solutions. This new offering comes on the heels of the company's announcement in 2019 of the expansion of its Ireland laboratory, from which Almac Sciences provides a comprehensive range of flexible pharmaceutical testing services to support clients' drug development programs, while adhering to industry regulations such as the FDA, EMA, and PMDA under GMP standards.

Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments. 

Global Bioanalytical Testing Services Market Snapshot 

Attribute

Detail

Market Size Value in 2021

US$ 2.11 Bn

Market Forecast Value in 2031 

More than US$ 8.95 Bn

Compound Annual Growth Rate (CAGR)

15.7%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. 

Competition Landscape

  • Market share analysis/ranking by company (2021)

  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Testing Type
    • Cell-based Assays
    • Virology Testing
    • Serology, Immunogenicity, and Neutralizing Antibodies
    • Toxicology Services
    • Biomarker Testing
    • Pharmacokinetic Testing
    • Other services
  • Application
    • Oncology
    • Neurology
    • Metabolic Disorders
    • Hematology
    • Immunology
    • Orthopedics
    • Others
  • End-user
    • Biotech & Pharmaceuticals Company
    • CDMO & CMO
    • Clinical Research Organizations
    • Healthcare Institutes
  • Technology
    • Mass Spectrometry
    • Chromatography

Regions Covered

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Countries Covered

  • U.S.

  • Canada

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • China

  • India

  • Japan

  • Australia & New Zealand

  • Brazil

  • Mexico

  • GCC Countries

  • South Africa

Companies Profiled

  • Charles River Laboratories International, Inc.,

  • Bioreliance Corporation

  • Intertek Group plc

  • Eurofins Scientific SE

  • BioclinResearch Laboratories

  • Labcorp

  • Wuxi AppTec

  • Envigo

  • BioAgilytix Labs

  • SyneosHealth

  • Frontage Labs

Customization Scope

Available upon request

Pricing

Available upon request

Bioanalytical Testing Services Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global bioanalytical testing services market in 2021?

The global bioanalytical testing services market was valued at US$ 2.11 Bn in 2021.

How big will be the global bioanalytical testing services market by 2031?

The global bioanalytical testing services market is projected to reach more than US$ 8.95 Bn by 2031.

What was the CAGR of the global bioanalytical testing services market from 2017 to 2021?

The global bioanalytical testing services market grew at a CAGR of 6% from 2017 to 2021.

What will be the CAGR of the global bioanalytical testing services market during the forecast period (2022–2031)?

The global bioanalytical testing services market is anticipated to grow at a CAGR of 15.7% from 2022 to 2031.

Which are the prominent trends that affect market growth?

Rise in investment in R&D facilities, surge in demand for biopharma products, and increase in need to develop novel bioanalytical testing platforms are the key factors driving the global market.

What was the market share of the leading segment of the global bioanalytical testing services market?

The cell-based bioassay segment accounted for more than 30% share of the global bioanalytical testing services market in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global market during the forecast period.

Who are the prominent players in the global bioanalytical testing services market?

Charles River Laboratories International Inc., Bioreliance Corporation, Intertek Group plc, Eurofins Scientific SE, BioclinResearch Laboratories, Labcorp, Wuxi AppTec, Envigo, BioAgilytix Labs, SyneosHealth, and Frontage Labs are the prominent players operating in the global bioanalytical testing services market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bioanalytical Testing Services Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Bioanalytical Testing Services Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Pipeline Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Bioanalytical Testing Services Market Analysis and Forecast, by Testing Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Testing Type, 2017–2031

        6.3.1. Cell-based Assays

        6.3.2. Virology Testing

        6.3.3. Serology, Immunogenicity, and Neutralizing Antibodies

        6.3.4. Toxicology Services

        6.3.5. Biomarker Testing

        6.3.6. Pharmacokinetic Testing

        6.3.7. Other services

    6.4. Market Attractiveness Analysis, by Testing Type

7. Global Bioanalytical Testing Services Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Oncology

        7.3.2. Metabolic Disorders

        7.3.3. Neurology

        7.3.4. Hematology

        7.3.5. Orthopedics

        7.3.6. Immunology

        7.3.7. Other

    7.4. Market Attractiveness Analysis, by Application

8. Global Bioanalytical Testing Services Market Analysis and Forecast, by Technology

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Technology, 2017–2031

        8.3.1. Mass Spectrometry

        8.3.2. Chromatography

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by Technology

9. Global Bioanalytical Testing Services Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Healthcare Institutes

        9.3.2. Biotech & Pharmaceuticals Company

        9.3.3. CDMO & CMO

        9.3.4. Clinical Research Organizations

    9.4. Market Attractiveness Analysis, by End-user

10. Global Bioanalytical Testing Services Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Bioanalytical Testing Services Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Testing Type, 2017–2031

        11.2.1. Cell-based Assays

        11.2.2. Virology Testing

        11.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

        11.2.4. Toxicology Services

        11.2.5. Biomarker Testing

        11.2.6. Pharmacokinetic Testing

        11.2.7. Other services

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Oncology

        11.3.2. Metabolic Disorders

        11.3.3. Neurology

        11.3.4. Hematology

        11.3.5. Orthopedics

        11.3.6. Immunology

        11.3.7. Other

    11.4. Market Value Forecast, by Technology, 2017–2031

        11.4.1. Mass Spectrometry

        11.4.2. Chromatography

        11.4.3. Others

    11.5. Market Value Forecast, by End-user, 2017–2031

        11.5.1. Healthcare Institutes

        11.5.2. Biotech & Pharmaceuticals Company

        11.5.3. CDMO & CMO

        11.5.4. Clinical Research Organizations

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Testing Type

        11.7.2. By Application

        11.7.3. By Technology

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Bioanalytical Testing Services Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Testing Type, 2017–2031

        12.2.1. Cell-based Assays

        12.2.2. Virology Testing

        12.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

        12.2.4. Toxicology Services

        12.2.5. Biomarker Testing

        12.2.6. Pharmacokinetic Testing

        12.2.7. Other Services

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Oncology

        12.3.2. Metabolic Disorders

        12.3.3. Neurology

        12.3.4. Hematology

        12.3.5. Orthopedics

        12.3.6. Immunology

        12.3.7. Other

    12.4. Market Value Forecast, by Technology, 2017–2031

        12.4.1. Mass Spectrometry

        12.4.2. Chromatography

        12.4.3. Others

    12.5. Market Value Forecast, by End-user, 2017–2031

        12.5.1. Healthcare Institutes

        12.5.2. Biotech & Pharmaceuticals Company

        12.5.3. CDMO & CMO

        12.5.4. Clinical Research Organizations

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Testing Type

        12.7.2. By Application

        12.7.3. By Technology

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Bioanalytical Testing Services Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Testing Type, 2017–2031

        13.2.1. Cell-based Assays

        13.2.2. Virology Testing

        13.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

        13.2.4. Toxicology Services

        13.2.5. Biomarker Testing

        13.2.6. Pharmacokinetic Testing

        13.2.7. Other Services

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Oncology

        13.3.2. Metabolic Disorders

        13.3.3. Neurology

        13.3.4. Hematology

        13.3.5. Orthopedics

        13.3.6. Immunology

        13.3.7. Other

    13.4. Market Value Forecast, by Technology, 2017–2031

        13.4.1. Mass Spectrometry

        13.4.2. Chromatography

        13.4.3. Others

    13.5. Market Value Forecast, by End-user, 2017–2031

        13.5.1. Healthcare Institutes

        13.5.2. Biotech & Pharmaceuticals Company

        13.5.3. CDMO & CMO

        13.5.4. Clinical Research Organizations

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Testing Type

        13.7.2. By Application

        13.7.3. By Technology

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Bioanalytical Testing Services Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Testing Type, 2017–2031

        14.2.1. Cell-based Assays

        14.2.2. Virology Testing

        14.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

        14.2.4. Toxicology Services

        14.2.5. Biomarker Testing

        14.2.6. Pharmacokinetic Testing

        14.2.7. Other Services

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Oncology

        14.3.2. Metabolic Disorders

        14.3.3. Neurology

        14.3.4. Hematology

        14.3.5. Orthopedics

        14.3.6. Immunology

        14.3.7. Other

    14.4. Market Value Forecast, by Technology, 2017–2031

        14.4.1. Mass Spectrometry

        14.4.2. Chromatography

        14.4.3. Others

    14.5. Market Value Forecast, by End-user, 2017–2031

        14.5.1. Healthcare Institutes

        14.5.2. Biotech & Pharmaceuticals Company

        14.5.3. CDMO & CMO

        14.5.4. Clinical Research Organizations

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Testing Type

        14.7.2. By Application

        14.7.3. By Technology

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa Bioanalytical Testing Services Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Testing Type, 2017–2031

        15.2.1. Cell-based Assays

        15.2.2. Virology Testing

        15.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

        15.2.4. Toxicology Services

        15.2.5. Biomarker Testing

        15.2.6. Pharmacokinetic Testing

        15.2.7. Other Services

    15.3. Market Value Forecast, by Application, 2017–2031

        15.3.1. Oncology

        15.3.2. Metabolic Disorders

        15.3.3. Neurology

        15.3.4. Hematology

        15.3.5. Orthopedics

        15.3.6. Immunology

        15.3.7. Other

    15.4. Market Value Forecast, by Technology, 2017–2031

        15.4.1. Mass Spectrometry

        15.4.2. Chromatography

        15.4.3. Others

    15.5. Market Value Forecast, by End-user, 2017–2031

        15.5.1. Healthcare Institutes

        15.5.2. Biotech & Pharmaceuticals Company

        15.5.3. CDMO & CMO

        15.5.4. Clinical Research Organizations

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Testing Type

        15.7.2. By Application

        15.7.3. By Technology

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Company Profiles

    16.3. Company Profiles

        16.3.1. Charles River Laboratories International, Inc.

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. SWOT Analysis

            16.3.1.4. Strategic Overview

        16.3.2. Bioreliance Corporation

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. Intertek Group plc

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. SWOT Analysis

            16.3.3.4. Strategic Overview

        16.3.4. Eurofins Scientific SE

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. BioclinResearch Laboratories

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. Financial Overview

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. Labcorp

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. SWOT Analysis

            16.3.6.4. Strategic Overview

        16.3.7. Wuxi AppTec

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. Financial Overview

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. Envigo

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. BioAgilytix Labs

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. SWOT Analysis

            16.3.9.4. Strategic Overview

        16.3.10. SyneosHealth

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Product Portfolio

            16.3.10.3. SWOT Analysis

            16.3.10.4. Strategic Overview

        16.3.11. Frontage Labs

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.11.2. Product Portfolio

            16.3.11.3. SWOT Analysis

            16.3.11.4. Strategic Overview

List of Tables

Table 01: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

Table 02: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

Table 03: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 04: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Application, 2017‒2031

Table 05: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by technology, 2017‒2031

Table 06: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by technology, 2017‒2031

Table 07: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 08: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 09: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

Table 10: North America Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

Table 11: North America Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

Table 12: North America Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

Table 15: Europe Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

Table 16: Europe Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

Table 17: Europe Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 19: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

Table 20: Asia Pacific Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

Table 21: Asia Pacific Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

Table 22: Asia Pacific Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

Table 23: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

Table 25: Latin America Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

Table 26: Latin America Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

Table 27: Latin America Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

Table 28: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 29: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

Table 30: Middle-East & Africa Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

Table 31: Middle-East & Africa Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

Table 32: Middle-East & Africa Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Bioanalytical Testing Services Market Value Share, by Testing Type, 2021

Figure 03: Global Bioanalytical Testing Services Market Value Share, by Technology, 2021

Figure 04: Global Bioanalytical Testing Services Market Value Share, by Application, 2021

Figure 05: Global Bioanalytical Testing Services Market Value Share, by End-user, 2021

Figure 06: Global Bioanalytical Testing Services Market Value Share, by Region, 2021

Figure 07: Global Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

Figure 08: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

Figure 09: Global Bioanalytical Testing Services Market (US$ Mn), by Cell-based Assays, 2017–2031

Figure 10: Global Bioanalytical Testing Services Market (US$ Mn), by Virology Testing, 2017–2031

Figure 11: Global Bioanalytical Testing Services Market (US$ Mn), by Serology, Immunogenicity, and Neutralizing Antibodies, 2017–2031

Figure 12: Global Bioanalytical Testing Services Market (US$ Mn), by Toxicology Services, 2017–2031

Figure 13: Bioanalytical Testing Services Market (US$ Mn), by Biomarker Testing, 2017–2031

Figure 14: Global Bioanalytical Testing Services Market (US$ Mn), by Pharmacokinetic Testing, 2017–2031

Figure 15: Global Bioanalytical Testing Services Market (US$ Mn), by Other services, 2017–2031

Figure 16: Global Bioanalytical Testing Services Market, by Application, 2021 and 2031

Figure 17: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2022–2031

Figure 18: Global Bioanalytical Testing Services Market (US$ Mn), by Oncology, 2017–2031

Figure 19: Global Bioanalytical Testing Services Market (US$ Mn), by Metabolic Disorders, 2017–2031

Figure 20: Global Bioanalytical Testing Services Market (US$ Mn), by Neurology, 2017–2031

Figure 21: Global Bioanalytical Testing Services Market (US$ Mn), by Hematology, 2017–2031

Figure 22: Global Bioanalytical Testing Services Market (US$ Mn), by Orthopedics, 2017–2031

Figure 23: Global Bioanalytical Testing Services Market (US$ Mn), by Immunology, 2017–2031

Figure 24: Global Bioanalytical Testing Services Market (US$ Mn), by Other, 2017–2031

Figure 25: Global Bioanalytical Testing Services Market, by Technology 2021 and 2031

Figure 26: Global Bioanalytical Testing Services Market Attractiveness Analysis, Technology, 2022–2031

Figure 27: Global Bioanalytical Testing Services Market (US$ Mn), by Mass Spectrometry, 2017–2031

Figure 28: Global Bioanalytical Testing Services Market (US$ Mn), by Chromatography, 2017–2031

Figure 29: Global Bioanalytical Testing Services Market (US$ Mn), by Others, 2017–2031

Figure 30: Global Bioanalytical Testing Services Market, by End-user 2021 and 2031

Figure 31: Global Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

Figure 32: Global Bioanalytical Testing Services Market (US$ Mn), by Healthcare Institutes, 2017–2031

Figure 33: Global Bioanalytical Testing Services Market (US$ Mn), by Biotech & Pharmaceuticals Company, 2017–2031

Figure 34: Global Bioanalytical Testing Services Market (US$ Mn), by CDMO & CMO, 2017–2031

Figure 35: Global Bioanalytical Testing Services Market (US$ Mn), by Clinical Research Organizations, 2017–2031

Figure 36: Global Bioanalytical Testing Services Market Value Share Analysis, by Region, 2021 and 2031

Figure 37: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Region, 2022–2031

Figure 38: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 39: North America Bioanalytical Testing Services Market Value Share Analysis, by Country, 2021 and 2031

Figure 40: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Country, 2022–2031 

Figure 41: North America Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

Figure 42: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

Figure 43: North America Bioanalytical Testing Services Market, Technology, 2021 and 2031

Figure 44: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

Figure 45: North America Bioanalytical Testing Services Market, by Application, 2021 and 2031

Figure 46: North America Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031

Figure 47: North America Bioanalytical Testing Services Market, by End-user, 2021 and 2031

Figure 48: North America Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

Figure 49: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 50: Europe Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 51: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

Figure 52: Europe Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

Figure 53: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

Figure 54: Europe Bioanalytical Testing Services Market, Technology, 2021 and 2031

Figure 55: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

Figure 56: Europe Bioanalytical Testing Services Market, by Application, 2021 and 2031

Figure 57: Europe Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031

Figure 58: Europe Bioanalytical Testing Services Market, by End-user, 2021 and 2031

Figure 59: Europe Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

Figure 60: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 61: Asia Pacific Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 62: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

Figure 63: Asia Pacific Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

Figure 64: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

Figure 65: Asia Pacific Bioanalytical Testing Services Market, Technology, 2021 and 2031

Figure 66: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

Figure 67: Asia Pacific Bioanalytical Testing Services Market, by Application, 2021 and 2031

Figure 68: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031

Figure 69: Asia Pacific Bioanalytical Testing Services Market, by End-user, 2021 and 2031

Figure 70: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

Figure 71: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 72: Latin America Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 73: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

Figure 74: Latin America Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

Figure 75: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

Figure 76: Latin America Bioanalytical Testing Services Market, Technology, 2021 and 2031

Figure 77: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

Figure 78: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2021 and 2031

Figure 79: Latin America Bioanalytical Testing Services Market, Application, 2022–2031

Figure 80: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by End-user, 2021 and 2031

Figure 81: Latin America Bioanalytical Testing Services Market, End-user, 2022–2031

Figure 82: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

Figure 83: Middle-East & Africa Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 84: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

Figure 85: Middle-East & Africa Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

Figure 86: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

Figure 87: Middle-East & Africa Bioanalytical Testing Services Market, Technology, 2021 and 2031

Figure 88: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

Figure 89: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2021 and 2031

Figure 90: Middle-East & Africa Bioanalytical Testing Services Market, Application, 2022–2031

Figure 91: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by End-user, 2021 and 2031

Figure 92: Middle-East & Africa Bioanalytical Testing Services Market, End-user, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

737

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved